Eidos therapeutics, inc. (EIDX)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Sep'17Jun'17
License revenue

-

-

0

-

-

-

-

-

-

-

-

Operating costs and expenses:
Cost of license revenue

-

-

0

-

-

-

-

-

-

-

-

Research and development (includes related party expense (benefit) of $(242) and $94 for the three months ended March 31, 2020 and 2019, respectively)

55,917

46,891

41,356

37,738

31,436

28,539

22,499

15,391

0

0

0

General and administrative (includes related party expense of $285 and $79 for the three months ended March 31, 2020 and 2019, respectively)

19,027

17,751

14,667

11,333

10,930

9,240

7,348

5,183

0

0

0

Total operating expenses

77,444

67,142

58,523

49,071

42,366

37,779

29,847

20,574

0

0

0

Loss from operations

-50,753

-40,451

-31,832

-49,071

-42,366

-37,779

-29,847

-20,574

0

0

0

Interest expense

0

-

-

-

-

-

-

-

-

-

-

Other income (expense), net

2,672

2,943

4,134

3,828

-205

-1,935

0

0

0

-

-

Net and comprehensive loss

-48,926

-37,835

-28,709

-46,254

-43,582

-40,725

-33,644

-24,745

0

0

0

Deemed dividend related to redemption feature embedded in Convertible Promissory Notes payable to stockholders

-

-

-

-

-

6,523

0

0

0

-

-

Gain on extinguishment of Convertible Promissory Notes payable to stockholders

-

-

-

-

-

7,436

0

0

0

-

-

Net income (loss) attributable to common stock for basic and diluted net income (loss) per share

-

-

0

-

-

-

0

-

-

-

-

Net income (loss) per share attributable to common stockholders, basic

-

-

0.19

-

-

-

-0.30

-

-

-

-

Net income (loss) per share attributable to common stockholders, diluted

-

-

0.18

-

-

-

-0.30

-

-

-

-

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, basic

-

-

36,581

-

-

-

35,965

-

-

-

-

Weighted-average shares used in computing net income (loss) per share attributable to common stockholders, diluted

-

-

37,710

-

-

-

35,965

-

-

-

-

Net loss attributable to common stockholders

-

-

-

-46,254

-

-

-

0

0

-

-

Net loss per share - basic and diluted

-0.60

-

-

-0.39

-0.32

-

-

-1.40

-1.81

-0.74

-0.49

Weighted-average shares used in computing net loss per share - basic and diluted

38,009

-

-

36,309

36,175

-

-

8,109

4,392

3,752

3,514